Acute otitis externa: Treatment perspectives

Ear, Nose and Throat Journal

Volumn 83, Issue 9 SUPPL. 4, 2004, Pages 20-22

  Rutka, John ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Ear Pathology Research Laboratory

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UHN Multidisc Neurotology Clinic

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CIPROFLOXACIN; DEXAMETHASONE; DICLOFENAC; EAR DROPS; IBUPROFEN; NEOMYCIN; PARACETAMOL; ROFECOXIB; STEROID;

BACTERIAL INFECTION; CONFERENCE PAPER; CONTACT SENSITIVITY; DEBRIDEMENT; EXTERNAL AUDITORY CANAL; EXTERNAL OTITIS; HUMAN; MYCOSIS; PATCH TEST; PATHOPHYSIOLOGY; PH; RISK FACTOR;

EID: 12344274203     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/01455613040839s408     Document Type: Conference Paper

References (5)

1. Seyfried PL, Fraser DJ. Persistence of Pseudomonas aeruginosa in chlorinated swimming pools. Can J Microbiol 1980;26:350-5.
2. Driscoll PV, Ramachandrula A, Drezner DA, et al. Characteristics of cerumen in diabetic patients: A key to understanding malignant external otitis? Otolaryngol Head Neck Surg 1993;109:676-9.
3. Tsikoudas A, Jasser P, England RJ. Are topical antibiotics necessary in the management of otitis externa? Clin Otolaryngol 2002;27:260-2.
4. Diagnosis and treatment of acute otitis externa. An interdisciplinary update. Ann Otol Rhinol Laryngol Suppl 1999;176:1-23.
5. Schapowal A. Contact dermatitis to antibiotic ear drops is due to neomycin but not to ciprofloxacin [abstract]. Allergy 2001;56(suppl 68):148.